Vyxeos Liposomal: An overview of real-world evidence from four European studies

Back to resources

Key data for Vyxeos Liposomal from cohorts in England, France, Italy and Germany in the context of Study 301 results. All in a handy format you can access offline.

Prescribing Information can be found at the top of this page. Adverse event reporting is available at the bottom of this page.

Topics: Real-world Data Safety Vyxeos Liposomal Data

ADVERSE EVENTS REPORTING

Adverse events should be reported. Reporting forms and information for the UK can be found at https://yellowcard.mhra.gov.uk/

For Ireland, reporting forms and information can be found at: www.hpra.ie

Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com